Dyspermia in men with localized Hodgkin's disease. A potentially reversible, immune-mediated disorder

This publication has 36 references indexed in Scilit:

• Treatment with the Gonadotropin-Releasinghormone Agonist Buserelin to Protect Spermatogenesis against Cytotoxic Treatment in Young Men/Behandlung zum Schutz der Spermatogenese bei cytotoxischer Therapie mit dem Gonadotropin-Hormon Agonisten Buserelin
  Andrologia, 2009
• Testicular dysfunction in Hodgkin's disease before and after treatment
  European Journal of Cancer and Clinical Oncology, 1991
• Semen cryopreservation and artificial insemination for Hodgkin's disease.
  Journal of Clinical Oncology, 1987
• Semen analysis in Hodgkin's disease before the onset of treatment
  Cancer, 1986
• CRYOPRESERVATION OF SEMEN IN MEN WITH TESTICULAR TUMOUR OR HODGKIN'S DISEASE: RESULTS OF ARTIFICIAL INSEMINATION OF THEIR PARTNERS
  The Lancet, 1985
• Effect of a luteinizing hormone releasing hormone agonist given during combination chemotherapy on posttherapy fertility in male patients with lymphoma: preliminary observations
  Blood, 1985
• Semen Analysis in Testicular Cancer and Hodgkin's Disease: Pre‐ and Post‐Treatment Findings and Implications for Cryopreservation
  British Journal of Urology, 1983
• Testicular dysfunction in untreated Hodgkin's disease
  The American Journal of Medicine, 1982
• The effects of Hodgkin's disease and combination chemotherapy on gonadal function in the adult male
  Cancer, 1982
• Male Gonadal Dysfunction in Hodgkin's Disease
  JAMA, 1981